Original ArticlesBimodal cardiac dysfunction in an animal model of iron overload☆,☆☆
Section snippets
Methods
Experiments were conducted in 2-month-old female Mongolian gerbils. The investigation conformed to the “Guide for the Care and Use of Laboratory Animals” published by the National Institutes of Health (NIH publication no. 85-23, revised 1996). A low dose (200 mg iron/kg/week) and a high dose (800 mg iron/kg/week) of iron-dextran (ferric hydroxide-dextran complex, 100 mg/mL; Sigma Chemical Co, St Louis, Mo) were used in this study. The doses were injected subcutaneously; control animals were
Results
Table I shows that iron loading in accordance with low-dose (200 mg/kg/week) and high-dose (800 mg/kg/week) protocols resulted in greater terminal weights of the heart, liver, and body than those seen controls. Table II shows that both protocols resulted in dose- and time-dependent increases in cardiac and liver iron per gram of dry tissue. The iron levels measured in our experimental conditions were similar to those reported in autopsies of human beings with transfusional iron overload11, 19
Discussion
The progressive increase in cardiac iron content in our experiments was associated with a bimodal change in cardiac performance. Relatively short periods of iron overloading tend to enhance cardiac performance, whereas relatively long periods tend to impair cardiac performance. In the isolated working heart preparations derived from those animals that received the low-dose iron regimen for 20 weeks, the values of cardiac work and coronary flow were significantly greater than the corresponding
References (31)
- et al.
Iron-chelating therapy and the treatment of thalessemia
Blood
(1997) - et al.
Successful reversal by chelation therapy of congestive cardiomyopathy due to iron overload
J Am Coll Cardiol
(1986) - et al.
Regression of cardiac insufficiency after ambulatory intravenous deferoxamine in thalassemia major
Chest
(1993) - et al.
Long-term outcome of continuous 24-hour deferoxamine infusion via indwelling intravenous catheters in high-risk beta-thalassemia
Blood
(2000) - et al.
Iron in the heart: etiology and clinical significance
Am J Med
(1971) - et al.
The iron-loaded gerbil model revisited: effects of deferoxamine and deferiprione treatment
J Lab Clin Med
(2002) - et al.
Preclinical cardiac dysfunction in transfusion-dependent children and young adults detected with low-dose dobutamine stress echocardiography
J Am Soc Echocardiogr
(1998) - et al.
Right ventricular diastolic function in beta-thalassemia major: echocardiographic and clinical correlates
Am Heart J
(2001) - et al.
Cardiac-specific overexpression of calsequestrin results in left ventricular hypertrophy, depressed force-frequency relation and pulsus alternans in vivo
J Mol Cell Cardiol
(2000) Disorders of iron metabolism: iron deficiency and overload
Pathophysiology of iron overload
Ann N Y Acad Sci
A unique rodent model for both the cardiotoxic and hepatotoxic effects of prolonged iron-overload
Lab Invest
Tissue iron overload and mechanisms of iron-catalyzed oxidative injury
Adv Exp Med Biol
Late cardiac complications of chronic, severe, refractory anemia with hemochromatosis
Circulation
Reversal of haemochromatotic cardiomyopathy in beta thalassaemia by chelation therapy
Br Heart J
Cited by (26)
Consequences of parenteral iron-dextran loading investigated in minipigs. A new model of transfusional iron overload
2020, Blood Cells, Molecules, and DiseasesExperimental animal model to study iron overload and iron chelation and review of other such models
2015, Blood Cells, Molecules, and DiseasesCitation Excerpt :However, they did not find rats and mice to be suitable models for prolonged iron overload as they do not develop the same pathology as seen in man [31]. Subsequently many studies on the use of iron dextran subcutaneously in Mongolian gerbils to produce severe iron overload have been done to investigate a new iron chelator or to produce pathology similar to that seen in humans with iron overload [32,33]. This was later challenged by Kaiser et al. in 2003 where the literature showed that when the human and gerbil iron content in the liver and heart tissues in the iron overloaded state was compared, the hepatic and cardiac iron content in all gerbils was found to be higher than the similar human iron content [34].
Paradoxically, iron overload does not potentiate doxorubicin-induced cardiotoxicity in vitro in cardiomyocytes and in vivo in mice
2015, Toxicology and Applied PharmacologyIron induces protection and necrosis in cultured cardiomyocytes: Role of reactive oxygen species and nitric oxide
2010, Free Radical Biology and MedicineIron sufficient to cause hepatic fibrosis and ascites does not cause cardiac arrhythmias in the gerbil
2009, Translational ResearchCitation Excerpt :Gerbils were weighed weekly, and the injected dose was based on the body weight of the previous week. The literature describes various iron dosing protocols for gerbils, which include the original protocol of Carthew15 (1 g/kg followed by 6 weekly doses of 500 mg/kg) and the Brittenham groups high-dose protocol16-19 (800 mg/kg/week to 16 g). In preliminary experiments, we could not reproduce any of these protocols without rapid and severe morbidity requiring euthanasia.
- ☆
Supported by United States Public Health Service grants HL61642, HL62882 and HL61642-S1.
- ☆☆
Reprint requests: Arthur M Brown, MD, PhD, Rammelkamp Center for Education and Research, 2500 MetroHealth Drive, R301, Cleveland, OH 44109-1998; e-mail: [email protected].